Search
Yinuo Pharmaceuticals Achieves Successful Hong Kong Stock Exchange Listing
2025-08-15 /
Read about 0 minute
Author：小编
Yinuo Pharmaceuticals has successfully debuted on the main board of the Hong Kong Stock Exchange, marking an impressive opening surge of over 285%. Specializing in the realm of metabolic diseases, the company intends to allocate the funds raised from this initial public offering (IPO) towards accelerating the clinical trials and fostering the commercial expansion of its flagship product, Ispaglutide α.
-
C114 Communication Network -
Communication Home
7 X 24 Track global technological trends
